CCR2 and atherosclerosis: The first molecule that has been investigated in atherosclerosis pathogenesis is chemokine ligand 2 (CCL2), also known as monocyte chemoattractant protein-1 (MCP-1), and it works with receptor chemokine receptor type 2 (CCR2).